Fluticasone Propionate Spray, Metered
Product Images NDC 58602-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 58602-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Fluticasone Fig1)

FDA Label Image

Figure (Fluticasone Fig10)

Figure (Fluticasone Fig10)
Illustration showing a purple outline of a human nose with the text "1x" on both the left and right sides, indicating a single use or application per nostril.*
FDA Label Image

Figure (Fluticasone Fig11)

Figure (Fluticasone Fig11)
An instructional diagram depicting a stylized orange nose icon flanked by "2x" symbols on both left and right sides, indicating a dosage or usage instruction related to nasal spray application.*
FDA Label Image

Figure (Fluticasone Fig12)

Figure (Fluticasone Fig12)
Instructional illustration showing a metered nasal spray device with droplets being sprayed and an eye symbol crossed out, indicating the spray should not get into the eyes.*
FDA Label Image

Figure (Fluticasone Fig13)

FDA Label Image

Figure (Fluticasone Fig14)

Figure (Fluticasone Fig14)
An instructional diagram showing two parts of a nasal spray bottle: the blue spray actuator and the bottle, with upward and downward arrows indicating removal or assembly of the actuator onto the bottle.*
FDA Label Image

Figure (Fluticasone Fig15)

Figure (Fluticasone Fig15)
An instructional diagram labeled with the number '2' showing a nasal spray bottle with a blue cap positioned above the nostril, illustrating use of the nasal spray with droplets spraying downward into the nostril.*
FDA Label Image

Figure (Fluticasone Fig16)

Figure (Fluticasone Fig16)
An instructional illustration showing step 3 of nasal spray use: a blue nasal spray bottle with an arrow pointing downward toward the nozzle, indicating the direction for use or actuation.*
FDA Label Image

Figure (Fluticasone Fig17)

Figure (Fluticasone Fig17)
An illustration of a nasal spray bottle partially submerged in a blue-colored cup filled with water, demonstrating an aspect of nasal spray use or maintenance.*
FDA Label Image

Figure (Fluticasone Fig18)

FDA Label Image

Figure (Fluticasone Fig19)

Figure (Fluticasone Fig19)
Illustration showing the correct way to shake a FLUTICASONE PROPIONATE nasal spray bottle before use. The image depicts a hand holding the bottle with motion lines indicating a shaking action.*
FDA Label Image

Figure (Fluticasone Fig2)

FDA Label Image

Figure (Fluticasone Fig20)

Figure (Fluticasone Fig20)
An instructional illustration showing a hand holding a fluticasone propionate nasal spray bottle with the other hand removing the cap. The image demonstrates the initial step in using the nasal spray.*
FDA Label Image

Figure (Fluticasone Fig21)

Figure (Fluticasone Fig21)
An instructional illustration showing a person using a metered nasal spray, with the spray directed into one nostril. An arrow indicates the spraying action from the nasal spray device toward the nasal passage.*
FDA Label Image

Figure (Fluticasone Fig22)

Figure (Fluticasone Fig22)
An illustration showing a person using both hands to pinch their nose with fingers positioned on the sides of the nostrils. The eyes appear closed, depicting a nasal maneuver, possibly related to nasal spray use or nasal care.*
FDA Label Image

Figure (Fluticasone Fig23)

Figure (Fluticasone Fig23)
An instructional illustration demonstrating correct use of a nasal spray. It shows a person holding a metered nasal spray bottle near one nostril while gently pressing the other side of the nose, highlighting proper positioning and application technique.*
FDA Label Image

Figure (Fluticasone Fig24)

Figure (Fluticasone Fig24)
An instructional diagram illustrating the tip of a metered nasal spray device. The tip is highlighted and labeled with the word 'Tip' in green text, indicating the part of the device used for nasal administration.*
FDA Label Image

Figure (Fluticasone Fig25)

Figure (Fluticasone Fig25)
An instructional illustration showing a nasal spray bottle positioned near a simplified outline of a nose, with a dashed green line indicating the angle or direction for proper nasal spray administration.*
FDA Label Image

Figure (Fluticasone Fig26)

Figure (Fluticasone Fig26)
An instructional diagram showing a person using a nasal spray bottle. The individual holds the spray bottle with one finger pointing toward the nostril, while the other hand supports the nose, demonstrating proper administration of the nasal spray.*
FDA Label Image

Package Label.principal Display Panel (50 mcg per spray (60 Metered Sprays, Bottle Label))

Package Label.principal Display Panel (50 mcg per spray (60 Metered Sprays, Bottle Label))
Label for Fluticasone Propionate Nasal Spray, USP 50 mcg per spray, a metered nasal spray for allergy symptom relief. The label states 120 metered sprays in a 0.54 fl oz (15.8 mL) bottle, distributed by Aurohealth LLC, made in India, with storage and usage instructions printed.*
FDA Label Image

Figure (Fluticasone Fig28)

Figure (Fluticasone Fig28)
Packaging label for Fluticasone Propionate Nasal Spray, USP 50 mcg per spray by Aurohealth LLC. This non-drowsy allergy symptom reliever provides 24-hour relief for nasal congestion, itchy and watery eyes, itchy nose, runny nose, and sneezing. The package contains 120 metered sprays in a 0.54 fl oz (15.8 mL) bottle. Distributed by Aurohealth LLC, East Windsor, NJ.*
FDA Label Image

Figure (Fluticasone Fig3)

Figure (Fluticasone Fig3)
An illustration showing allergens triggering a cell, which then releases inflammatory substances. The diagram visually explains a cellular response to allergens, labeled with 'Allergens,' 'Triggered Cell,' and 'Inflammatory Substances.'*
FDA Label Image

Figure (Fluticasone Fig4)

Figure (Fluticasone Fig4)
An instructional illustration showing the proper method for administering a nasal spray. It depicts the nasal spray bottle being inserted into the nostril with an arrow indicating the spray direction, along with a depiction of breath or airflow guidance.*
FDA Label Image

Figure (Fluticasone Fig5)

Figure (Fluticasone Fig5)
An illustrated diagram categorizing common allergy-related symptoms and triggers. It lists nasal symptoms (congestion, runny nose, sneezing, itchy nose), eye symptoms (itchy eyes, watery eyes), and allergen triggers including outdoor allergens (weed, grass, tree pollen), animal allergens (cats, dogs), and indoor allergens (dust, dust mites, mold).*
FDA Label Image

Figure (Fluticasone Fig6)

FDA Label Image

Figure (Fluticasone Fig7)

Figure (Fluticasone Fig7)
An instructional illustration showing a green nasal spray bottle directing spray toward an eye with a red prohibition symbol indicating not to spray into the eye.*
FDA Label Image

Figure 8 (Fluticasone Fig8)

FDA Label Image

Figure (Fluticasone Fig9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.